University of Oxford spin - out Brainomix has secured £ 7 m ( $ 9.8 m ) to market its artificial intelligence ( AI ) e - Aspects software . The company said the system offers a " fast and standardised collection of stroke patient CT scans " , and helps reduce the cost of surgery . Brainomix 's CEO , Michalis Papadakis , said the company will focus on expanding both its software and global footprint . The company is seeking approval for the software from the uk 's Food and Drug Administration .
University of Oxford spin-out Brainomix has secured £7m ($9.8m) to market its artificial intelligence (AI) e-Aspects software. The company said the system offers a "fast and standardised assessment of stroke patient CT scans", and helps reduce the cost of treatment. Brainomix's CEO, Michalis Papadakis, said the firm would focus on expanding both its software and global footprint. The company is awaiting approval for the software from the US's Food and Drug Administration.